(KMOX) – A British drug manufacturer is hoping for a
big score from consumers and a green light from the FDA for its medical
marijuana mouth spray in 2013.
Seven countries including the UK, Spain and Germany have approved
Sativex to treat patients with multiple sclerosis. Makers GW
Pharmaceuticals hopes the drug will be used as a prescribed replacement
to medical marijuana in the United States.
Patients take the drug by spraying it into their mouths like a breath
spray with a dosage meter. This way, GW Pharmaceuticals says people can
derive maximum benefit from the drug without feeling a “high.”